Sang-Joon Lee
Amministratore Delegato presso HYUNDAI PHARMACEUTICAL CO., LTD.
Patrimonio netto: 4 M $ in data 31/05/2024
Profilo
Sang-Joon Lee is currently the President, CEO, Director, and Head of R&D at Hyundai Pharmaceutical Co., Ltd.
He is also the Chief Executive Officer at Bioinnotis.
Mr. Lee holds an MBA from the University of San Diego.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/02/2023 | 1 351 612 ( 4.22% ) | 4 M $ | 31/05/2024 |
Posizioni attive di Sang-Joon Lee
| Società | Posizione | Inizio |
|---|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Amministratore Delegato | 28/02/2003 |
Bioinnotis
 Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Amministratore Delegato | - |
Formazione di Sang-Joon Lee
| University of San Diego | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Bioinnotis
Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Commercial Services |
- Borsa valori
- Insiders
- Sang-Joon Lee
